Krsnaa Diagnostics informs about outcome of board meeting

12 Feb 2025 Evaluate

In compliance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Krsnaa Diagnostics has informed that the Board of Directors of the Company at its meeting held today February 12, 2025, approved and/or took note of the following items: a) Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended December 31, 2024; b) Cessation of Yash Mutha from the designation of Manager. c) Appointment of Yash Mutha (DIN 07285523) as Managing Director of the Company. d) Updated Policy on Code of Practices and Procedures for Fair disclosure of Unpublished Price Sensitive Information formulated in terms of Regulation 8 of SEBI (Prohibition of Insider Trading) Regulations, 2015. e) List of the Key Managerial Personnel’s (KMP) for the purpose of determining the materiality of an event or information. Accordingly, it has enclosed the following: a) Limited Review Report and Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended December 31, 2024. The Board Meeting commenced at 09:30 Hrs. (IST) and concluded at 15:10 Hrs. (IST). The aforesaid results are also being disseminated on the Company’s Website. 

The above information is a part of company’s filings submitted to BSE.

Krsnaa Diagnostics Share Price

762.95 7.50 (0.99%)
05-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7193.05
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1918.30
Aster DM Healthcare 635.10
Global Health 1171.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×